Reduction of hippocampal hyperactivity improves cognition in amnestic mild cognitive impairment.

Neuron
Arnold BakkerMichela Gallagher

Abstract

Elevated hippocampal activation is observed in conditions that confer risk for Alzheimer's disease, including amnestic mild cognitive impairment (aMCI). Studies in relevant animal models have indicated that overactivity in selective hippocampal circuits contributes to cognitive impairment. Here, we tested the effect of reducing hippocampal activation in aMCI. Under placebo treatment, hippocampal activation in the dentate gyrus/CA3 was elevated in aMCI patients compared to a healthy control group. By using a low dose of the antiepileptic levetiracetam hippocampal activation in aMCI was reduced to a level that did not differ from the control group. Compared to aMCI memory performance under placebo, performance in the scanning task was significantly improved under drug treatment. Contrary to the view that greater hippocampal activation might serve a beneficial function, these results support the view that increased hippocampal activation in aMCI is a dysfunctional condition and that targeting excess hippocampal activity has therapeutic potential.

References

Jun 1, 1996·Computers and Biomedical Research, an International Journal·R W Cox
Dec 25, 2002·Neurobiology of Aging·I A WilsonH Tanila
Jul 6, 2004·Annals of Neurology·Bradford C DickersonReisa A Sperling
Jul 24, 2004·Science·Stefan LeutgebEdvard I Moser
Jul 22, 2005·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Iain A WilsonHeikki Tanila
Sep 26, 2006·Neurobiology of Aging·Anne HämäläinenHilkka Soininen
Oct 19, 2006·Trends in Neurosciences·Iain A WilsonHeikki Tanila
Nov 30, 2006·Human Brain Mapping·C Brock KirwanCraig E L Stark
Sep 13, 2007·Learning & Memory·C Brock Kirwan, Craig E L Stark
Nov 17, 2007·Learning & Memory·Stefan Leutgeb, Jill K Leutgeb
Mar 22, 2008·Science·Arnold BakkerCraig E L Stark
May 1, 2009·Learning & Memory·Chelsea K TonerPaul E Gilbert
Dec 25, 2009·Neuropsychopharmacology : Official Publication of the American College of Neuropsychopharmacology·Ming Teng KohMichela Gallagher
May 3, 2011·Nature Neuroscience·Adam W BeroDavid M Holtzman

❮ Previous
Next ❯

Citations

Aug 21, 2013·Cell and Tissue Research·John Talpos, Thomas Steckler
Aug 8, 2012·Proceedings of the National Academy of Sciences of the United States of America·Pascal E SanchezLennart Mucke
Aug 2, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Sunggu YangAlfredo Kirkwood
Aug 2, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Sarah L DeVosTimothy M Miller
Nov 3, 2012·Epilepsy Currents·Helen E Scharfman
Jan 8, 2014·Annual Review of Pharmacology and Toxicology·Karen Chiang, Edward H Koo
Jan 30, 2014·Nature Neuroscience·Michael A Yassa
Apr 5, 2014·Neurobiology of Aging·Rebecca C KleinScott D Moore
Jul 12, 2014·Brain : a Journal of Neurology·John L RobinsonJohn Q Trojanowski
Jul 9, 2014·Proceedings of the National Academy of Sciences of the United States of America·Martin J ChadwickEleanor A Maguire
Sep 15, 2014·Nature Neuroscience·Jeremy A ElmanWilliam J Jagust
Nov 15, 2013·The Journal of Neuroscience : the Official Journal of the Society for Neuroscience·Lori L Beason-HeldSusan M Resnick
Feb 13, 2016·Cell·Bart De Strooper, Eric Karran
Mar 5, 2016·NeuroImage. Clinical·Chris M FosterKelly S Giovanello
Dec 5, 2014·Amyloid : the International Journal of Experimental and Clinical Investigation : the Official Journal of the International Society of Amyloidosis·Shuan-Cheng RenZhi-Ru Zhu
Jun 4, 2013·Biological Psychiatry·Giovanna ZamboniClare E Mackay
Dec 3, 2014·Schizophrenia Research·Stephan Heckers, Christine Konradi
Feb 6, 2013·Ageing Research Reviews·Stephanie L Leal, Michael A Yassa
Jan 8, 2013·Biological Psychiatry·Yvette I Sheline, Marcus E Raichle
Feb 26, 2016·Nature Neuroscience·Samuel Frere, Inna Slutsky
Jan 7, 2016·Annals of Clinical and Translational Neurology·Meaghan MorrisLennart Mucke
Jun 8, 2012·Trends in Cognitive Sciences·Mark G Baxter
Dec 8, 2015·Journal of Alzheimer's Disease : JAD·Carola StockburgerWalter E Müller
Jan 9, 2016·Metabolic Brain Disease·Holly C HunsbergerMiranda N Reed
Mar 11, 2015·Current Biology : CB·Masashi TabuchiMark N Wu
Nov 27, 2015·Trends in Neurosciences·Stephanie L Leal, Michael A Yassa
Nov 20, 2015·Frontiers in Neuroscience·Davide Tampellini

❮ Previous
Next ❯

Related Concepts

Related Feeds

Attention Disorders

Attention is involved in all cognitive activities, and attention disorders are reported in patients with various neurological diseases. Here are the latest discoveries pertaining to attention disorders.

Alzheimer's Disease: Neuroimaging

Neuroimaging can help identify pathological hallmarks of Alzheimer's disease (AD). Here is the latest research on neuroimaging modalities, including magnetic resonance imaging and positron emission tomography, in AD.

Brain developing: Influences & Outcomes

This feed focuses on influences that affect the developing brain including genetics, fetal development, prenatal care, and gene-environment interactions. Here is the latest research in this field.

© 2021 Meta ULC. All rights reserved